BE904233A - PEPTIDES AND PEPTIDE DERIVATIVES, THEIR PREPARATION, THEIR USE IN THERAPEUTICS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. - Google Patents

PEPTIDES AND PEPTIDE DERIVATIVES, THEIR PREPARATION, THEIR USE IN THERAPEUTICS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

Info

Publication number
BE904233A
BE904233A BE1/011438A BE1011438A BE904233A BE 904233 A BE904233 A BE 904233A BE 1/011438 A BE1/011438 A BE 1/011438A BE 1011438 A BE1011438 A BE 1011438A BE 904233 A BE904233 A BE 904233A
Authority
BE
Belgium
Prior art keywords
peptides
therapeutics
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
BE1/011438A
Other languages
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE904233A publication Critical patent/BE904233A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0227—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Les peptides de formule I éventuellement sous forme isotère dans lesquels un groupe méthylène situé dans la chaine est disubstitué, un des substituants ou les deux étant le fluor et/ou de chlore. Ces composés peuvent etre utilisés comme médicaments, en particulier comme inhibiteurs de la rénine.The peptides of formula I optionally in isoteric form in which a methylene group located in the chain is disubstituted, one of the substituents or both being fluorine and / or chlorine. These compounds can be used as drugs, in particular as renin inhibitors.

BE1/011438A 1985-02-19 1986-02-17 PEPTIDES AND PEPTIDE DERIVATIVES, THEIR PREPARATION, THEIR USE IN THERAPEUTICS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. BE904233A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70265185A 1985-02-19 1985-02-19

Publications (1)

Publication Number Publication Date
BE904233A true BE904233A (en) 1986-08-18

Family

ID=24822094

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/011438A BE904233A (en) 1985-02-19 1986-02-17 PEPTIDES AND PEPTIDE DERIVATIVES, THEIR PREPARATION, THEIR USE IN THERAPEUTICS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

Country Status (7)

Country Link
JP (1) JPS61194097A (en)
BE (1) BE904233A (en)
CH (1) CH672792A5 (en)
DE (1) DE3604510A1 (en)
FR (1) FR2577557B1 (en)
GB (1) GB2171103B (en)
IT (1) IT1203743B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5194588A (en) * 1985-01-22 1993-03-16 Ici Americas Inc. Aminoalcohol intermediates for peptide derivatives
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
US5055450A (en) * 1985-01-22 1991-10-08 Ici Americas Inc. Peptide derivatives
US5496927A (en) * 1985-02-04 1996-03-05 Merrell Pharmaceuticals Inc. Peptidase inhibitors
US4882420A (en) * 1985-04-19 1989-11-21 The Upjohn Company Dihalo-statine substituted renin inhibitors
GB8613704D0 (en) * 1986-06-05 1986-07-09 Ici America Inc Difluoro keto compounds
GB8613703D0 (en) * 1986-06-05 1986-07-09 Ici America Inc Difluoro peptide compounds
GB8619182D0 (en) * 1986-08-06 1986-09-17 Sandoz Ltd Peptides & derivatives
NZ223148A (en) * 1987-01-16 1989-10-27 Merrell Dow Pharma Peptide derivatives having peptidase inhibition activity
US4855303A (en) * 1987-07-01 1989-08-08 Pfizer Inc. Fluorine containing renin inhibitors
US5071837A (en) * 1990-11-28 1991-12-10 Warner-Lambert Company Novel renin inhibiting peptides
US5559140A (en) * 1991-01-02 1996-09-24 Merrell Pharmaceuticals Inc. Difluoro statone analogs
CA2098020C (en) * 1991-01-02 2003-10-21 Daniel Schirlin Anti-viral compounds
IL108031A0 (en) * 1992-12-22 1994-04-12 Procter & Gamble Difluoro pentapeptide derivatives and pharmaceutical compositions containing them
AU667995B2 (en) * 1993-02-15 1996-04-18 Bayer Aktiengesellschaft New pseudopeptides having an antiviral action
EP0707564B1 (en) * 1993-07-08 2000-09-20 Merrell Pharmaceuticals Inc. Difluoro statone analogs
KR100308839B1 (en) * 1993-09-09 2002-10-04 메렐 파마슈티칼스 인크. Difluoro startone antiviral analogs
WO1995021186A1 (en) * 1994-02-04 1995-08-10 Merrell Pharmaceuticals Inc. Macrocyclic difluorostatone derivatives useful as antiviral agents
GB9502152D0 (en) * 1995-02-03 1995-03-29 Zeneca Ltd Proline derivatives
US6114380A (en) * 1995-12-18 2000-09-05 Merrell Pharmaceuticals Inc. Difluoro statone analogs
US8324347B2 (en) * 2009-02-24 2012-12-04 Institute For Systems Biology Methods of using halogenated peptides as internal standards for liquid chromatography-mass spectrometry

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2424253A1 (en) * 1978-04-27 1979-11-23 Brun Lab Sa Le NEW DERIVATIVES OF PEPTIDES ANALOGUES OF ENKEPHALINS, THEIR METHOD OF PREPARATION AND THEIR THERAPEUTIC APPLICATION
EP0048159A3 (en) * 1980-09-17 1982-05-12 University Of Miami Novel carboxyalkyl peptides and thioethers and ethers of peptides as antihypertensive agents
EP0218688B1 (en) * 1985-04-19 1990-09-12 The Upjohn Company Dihalo-statine substituted renin inhibitors

Also Published As

Publication number Publication date
FR2577557A1 (en) 1986-08-22
CH672792A5 (en) 1989-12-29
IT8647666A0 (en) 1986-02-18
DE3604510A1 (en) 1986-08-21
GB8603835D0 (en) 1986-03-26
FR2577557B1 (en) 1990-05-11
JPS61194097A (en) 1986-08-28
GB2171103A (en) 1986-08-20
IT1203743B (en) 1989-02-23
GB2171103B (en) 1989-01-25

Similar Documents

Publication Publication Date Title
BE904233A (en) PEPTIDES AND PEPTIDE DERIVATIVES, THEIR PREPARATION, THEIR USE IN THERAPEUTICS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
MY101791A (en) New benzimidazole derivatives
IT8423523A0 (en) PROCEDURE AND COMPOSITION FOR THE PREPARATION OF CONTROLLED LONG-ACTING PHARMACEUTICAL PRODUCTS FOR ORAL ADMINISTRATION.
ATE45153T1 (en) BENZISOSELENAZOLTHIONES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL PRODUCTS CONTAINING THESE COMPOUNDS.
LV10954A (en) Derivatives of benzimidazole as a result of their acquisition and their pharmaceutical composition
MX9203417A (en) ANTIATEROESCLEROTIC DIARILO COMPOUNDS.
GR1001597B (en) Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same.
BE1002213A5 (en) NOVEL PEPTIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS.
FR2610196B1 (en) POTASSIUM CLAVULANATE, METHODS OF PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND USE AS ANTIBACTERIAL AGENTS
OA07539A (en) New derivatives of phenyl aliphatic acids, their preparation, their application as medicaments, and the compositions containing them.
IT8521322A0 (en) PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS FOR THE THERAPY OF RETINOPATHIES AND DIABETIC NEUROPATHIES.
ES453162A1 (en) 6-Oxa-1-aza tricyclo dodecan-5-ones as psychomotor stimulators
ATE13488T1 (en) GALLIUM CHLORIDE, A NEW ANTI-CANCER AGENT.
FR2640269B1 (en) ORGANOMETALLIC COMPOUNDS, METHODS OF PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE40987T1 (en) ACETYLENIC PHENOXYPROPANOL DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HIGH BLOOD PRESSURE.
ES8305342A1 (en) Thiazoline derivatives, their preparation and use and pharmaceutical preparations containing them.
OA08130A (en) Pharmaceutical or veterinary compositions containing thiosulfonate derivatives.
FR2609392B1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING PYRANOQUINOLEINS
GB1353832A (en) Sulphonium compounds of alpha-hydroxy-gamma-alkyl-mercapto butyric acid
AT342761B (en) PROCESS FOR THE PREPARATION OF HOMOPYRIMIDAZOLE DERIVATIVES CONTAINING STABLE PHARMACEUTICAL PREPARATIONS FOR ORAL ADMINISTRATION
WO1987004435A3 (en) Xanthine compounds
ATE39697T1 (en) ERYTHROMYCIN-A-SALT WITH MUCOSECRETOLYTIC AND FLUIDIZING ACTIVITY, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THIS.
GB1451559A (en) Benzimidazoles
GB1309868A (en) Benzodiazepine derivativers and a aprocess for the manufacture thereof
IT1251496B (en) Imidazothiadiazole derivatives having diuretic activity, processes for their preparation and compounds containing them

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SANDOZ S.A.

Effective date: 19930228